Good news! UNAIDS and WHO have released results from HIV transmission studies today:
"Results announced today from two studies reveal that a daily antiretroviral tablet taken by people who do not have HIV infection can reduce their risk of acquiring HIV by up to 73%. Both daily tenofovir and daily tenofovir/emtricitabine taken as preventive medicine (PrEP - pre-exposure prophylaxis) can prevent heterosexual transmission of HIV from men to women and from women to men."
This is great news for injecting-drug users, sex workers, and people who are in high risk groups.
No comments:
Post a Comment